Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
6
Number of overlapping holdings
27.3%
% of MSGR's 23 holdings also in IDNA
12.8%
% of IDNA's 51 holdings also in MSGR
Overlap by Weight
Sector Drift (MSGR minus IDNA)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in MSGR |
Weight in IDNA |
Overlap | |
---|---|---|---|---|
SAREPTA THERAPEUTICS INC | 5.1% | 5.3% | 5.1% | |
MODERNA, INC. | 6.2% | 5.0% | 5.0% | |
BIONTECH SE SPONSORED ADR | 6.1% | 3.4% | 3.4% | |
ALCOBRA LTD | 7.6% | 0.9% | 0.9% | |
INTELLIA THERAPEUTICS, INC. | 4.6% | 0.5% | 0.5% |
Position Highlights (Non-Overlapping Exposures)
MSGR Overweight Relative to IDNA
VERTEX PHARMACEUTICALS INC | 8.1% | |
BEIGENE LTD. SPONSORED ADR | 7.6% | |
ALCOBRA LTD | 6.7% | |
ALNYLAM PHARMACEUTICALS INC | 6.4% | |
PTC THERAPEUTICS INC | 5.7% | |
MARAVAI LIFESCIENCES HOLDINGS INC CL | 4.9% | |
IONIS PHARMACEUTICALS, INC. | 4.1% | |
INTELLIA THERAPEUTICS, INC. | 4.1% | |
ARROWHEAD PHARMACEUTICALS, INC. | 3.7% | |
AVIDITY BIOSCIENCES INC | 3.4% |
MSGR Underweight Relative to IDNA
REVOLUTION MEDICINES, INC. | -5.6% | |
MERCK & CO. INC. | -4.7% | |
REGENERON PHARMACEUTICALS | -4.3% | |
EXELIXIS INC | -4.0% | |
SANOFI-AVENTIS | -3.9% | |
INCYTE CORP | -3.8% | |
TAKEDA PHARMACEUTICAL CO LTD | -3.6% | |
GENMAB A/S | -3.6% | |
ROCHE HOLDING LTD | -3.5% | |
GILEAD SCIENCES INC | -3.4% |